An array of tumor-derived chemoattractants such as CSF1, CSF2, CCL2, VEGFA, and SEMA3A contribute to the recruitment of monocytic precursors, resulting in TAMs accumulation1,32–34,51–53. The gene discussed is SEMA3A; the disease is neoplasm.